Does every affected service reflect the same authorised medication change?
Turn medication changes into owned events with provenance, acknowledgement, reconciliation and closure across organisational boundaries.
Commissioner summary
Three medicines problems. One controlled evaluation. One decision at week 20.
Sitora proposes a governed medicines-intelligence pilot covering cross-setting medication reconciliation, preventable repeat oversupply and evidence-backed resource opportunities.
Core workflowLoop
Medicine Loop
Close authorised medication changes across hospital, GP, pharmacy, care-home and community workflows.Waste preventionNeed?
WasteGuard
Identify repeat supply that may no longer be required before avoidable dispensing occurs.ResourcePathway?
Resource Intelligence
Identify clinically appropriate pathway changes worth measuring locally.Decision20 weeks
Scale / modify / stop
The evaluation ends with a commissioning decision, not an open-ended programme.The proposition
Fix information loss, avoid unnecessary supply, then recover capacity.
Should this repeat item actually be supplied again now?
Use timing, cumulative supply, stock and medication-change signals to trigger proportionate human review before unnecessary dispensing.
If treatment is needed, is the pathway using avoidable resource?
Use published evidence and local measurement to prioritise route, formulation, preparation and capacity opportunities.
What Sitora is
An intelligence and accountability layer, not a replacement prescribing system.
01
Receive
Read the minimum required medication, supply and pathway signals.
02
Detect
Identify a conflict, oversupply signal or resource opportunity.
03
Route
Assign the next action to the responsible organisation or professional.
04
Close
Record acknowledgement, reconciliation or governed implementation.
05
Verify
Measure safety, workload, financial effect and reusable capacity.
The ask
What we need from an NHS partner.
- Approve a 20-week discovery and controlled pilot
- Nominate one acute provider plus a limited primary-care, pharmacy and care-setting cohort
- Nominate executive, clinical, pharmacy, digital/IG, finance and evaluation leads
- Permit access to the minimum agreed datasets and workflow interfaces
- Approve clinical-safety and intervention protocols before live action
- Agree benefit definitions and balancing measures before baseline begins
Safety boundary
No silent overwrite. No autonomous prescribing change.
Conflicting medication states remain visible until an accountable professional reconciles them. Clinically significant changes remain under authorised professional control.
Success rule
Recovery has to be demonstrated, not inferred.
SafetyClinical
No unacceptable harm
Medication discrepancies, missed doses and adverse effects monitored.WorkloadNet
No hidden burden
New pharmacist, GP and nursing work is counted.CapacityHours
Reusable release
Time only counts when it is demonstrably available for other activity.Money£
Finance validated
Cash release and cost avoidance remain separate.Week 20
Three legitimate outcomes: scale, modify or stop.
The proposal is intentionally falsifiable. If the opportunity is too small, unsafe or creates more work than it removes, the correct answer is to stop.